Biodesix Inc. (BDSX) Reports In-Line Q3 EPS

Biodesix Inc. (NASDAQ: BDSX) reported Q3 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $18.2 million versus the consensus estimate of $18.57 million.

For earnings history and earnings-related data on Biodesix Inc. (BDSX) click here.

You May Also Be Interested In

• Kura Oncology (KURA) Tops Q2 EPS by 11c, Beats on Revenue
• Wendy's (WEN) 84K options contracts trade compared to its 90-day average of 18K contracts as share price up 13.4%
• Ascend Wellness Holdings, Inc. (AAWH) Tops Q2 EPS by 3c